Prelude Capital Management’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-756
| Closed | -$4K | – | 1982 |
|
|
2020
Q2 | $4K | Buy |
+756
| New | +$4K | ﹤0.01% | 1192 |
|
|
2020
Q1 | – | Sell |
-1,965
| Closed | -$8K | – | 1707 |
|
|
2019
Q4 | $8K | Sell |
1,965
-475
| -19% | -$1.93K | ﹤0.01% | 1262 |
|
|
2019
Q3 | $11K | Sell |
2,440
-57
| -2% | -$257 | ﹤0.01% | 1013 |
|
|
2019
Q2 | $10K | Sell |
2,497
-93
| -4% | -$372 | ﹤0.01% | 1024 |
|
|
2019
Q1 | $14K | Sell |
2,590
-67
| -3% | -$362 | ﹤0.01% | 992 |
|
|
2018
Q4 | $14K | Buy |
2,657
+2,073
| +355% | +$10.9K | ﹤0.01% | 974 |
|
|
2018
Q3 | $6K | Sell |
584
-1,474
| -72% | -$15.1K | ﹤0.01% | 1257 |
|
|
2018
Q2 | $21K | Sell |
2,058
-262
| -11% | -$2.67K | ﹤0.01% | 1079 |
|
|
2018
Q1 | $30K | Sell |
2,320
-18,728
| -89% | -$242K | ﹤0.01% | 1062 |
|
|
2017
Q4 | $377K | Buy |
21,048
+442
| +2% | +$7.92K | 0.03% | 430 |
|
|
2017
Q3 | $517K | Buy |
20,606
+69
| +0.3% | +$1.73K | 0.05% | 326 |
|
|
2017
Q2 | $495K | Sell |
20,537
-13,788
| -40% | -$332K | 0.05% | 292 |
|
|
2017
Q1 | $661K | Buy |
34,325
+15,486
| +82% | +$298K | 0.06% | 273 |
|
|
2016
Q4 | $290K | Buy |
+18,839
| New | +$290K | 0.04% | 416 |
|